Literature DB >> 11028683

Adrenergically stimulated fat utilization and ageing.

E E Blaak.   

Abstract

Ageing is associated with a diminished ability to use fat as a fuel during exercise. Also, middle-aged subjects have a blunted ability to mobilize fatty acids and to increase skeletal muscle fatty acid uptake and oxidation during intravenous beta-adrenergic stimulation, indicating that the sympathetic nervous system may play a role in the disturbed fat utilization. The blunted lipolytic response may be related to disturbances at the receptor level, eg a diminished number or agonist affinity of beta-adrenoceptors, or at the postreceptor level, eg a diminished activity of the hormone-sensitive lipase complex. As the rates of fatty acid availability are not limiting during exercise or beta-adrenergic stimulation in the elderly, the lowered skeletal muscle fat oxidation is probably related to an age-related decline in the capacity of skeletal muscle to oxidize fatty acids. Factors responsible for this decline may be a diminished content of oxidative enzymes, an increased glycolytic flux inhibiting fatty acid transport into the mitochondria, or a diminished (possibly beta-adrenergically-mediated) activation of fatty acid transport. It remains to be determined to what extent disturbances of fat metabolism may be related to the ageing process per se or whether they are secondary to age-related changes in body fat distribution and level of physical activity. Nevertheless, the impairments in sympathetically mediated lipolysis and fat oxidation may be of importance in the age-related increase in adiposity and insulin resistance and may thus be one of the links between ageing and increased prevalence of chronic diseases, such as obesity, type 2 diabetes mellitus, and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028683     DOI: 10.3109/07853890008995942

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  8 in total

Review 1.  Influence of exercise on nutritional requirements.

Authors:  D R Pendergast; K Meksawan; A Limprasertkul; N M Fisher
Journal:  Eur J Appl Physiol       Date:  2010-11-16       Impact factor: 3.078

2.  Laparoscopic Roux-en-Y gastric bypass is effective and safe in over 55-year-old patients: a comparative analysis.

Authors:  Salvatore Giordano; Mikael Victorzon
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

3.  Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins.

Authors:  Guilherme M Puga; Christian Meyer; Sarah Everman; Lawrence J Mandarino; Christos S Katsanos
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

4.  Lipogenic regulators are elevated with age and chronic overload in rat skeletal muscle.

Authors:  D A Rivas; E P Morris; R A Fielding
Journal:  Acta Physiol (Oxf)       Date:  2011-04-22       Impact factor: 6.311

5.  The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.

Authors:  Abdul-Rahman F Diab; Emad M Abdurasul; Fadi H Diab
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

6.  Predictors of Inadequate Weight Loss After Laparoscopic Gastric Bypass for Morbid Obesity.

Authors:  Waleed Al-Khyatt; Rebecca Ryall; Paul Leeder; Javed Ahmed; Sherif Awad
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

Review 7.  Clinical considerations and mechanistic determinants of postprandial lipemia in older adults.

Authors:  Christos S Katsanos
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

8.  The Role of Storage Lipids in the Relation between Fecundity, Locomotor Activity, and Lifespan of Drosophila melanogaster Longevity-Selected and Control Lines.

Authors:  Neda Nasiri Moghadam; Martin Holmstrup; Tommaso Manenti; Marie Brandt Mouridsen; Cino Pertoldi; Volker Loeschcke
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.